When symptoms such as "noticing significant developmental delays in mobility, language, and social interaction since age two" ...

A visitor tries a surgery robot at the booth of Medtronic at the Medical Equipment & Healthcare Products Exhibition Area ...

New research brings scientists one step closer to understanding Rett Syndrome, a rare genetic disease that affects 1 in ...

Rett syndrome is a rare genetic disease affecting 1 in 10,000 newborn girls, characterized by sudden regression around 1 year ...

Researchers at the Josep Carreras Leukaemia Research Institute revealed a new aspect of Rett Syndrome’s pathogenesis that can ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Neurotech said the deal aligns with its proprietary composition and formulation consisting of certain cannabinoids at ...

Romi Loffler fears she will be among the hardest hit by East Renfrewshire Council's decision to means-test and charge for ...

Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...

Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, ...

Company to host a webcasttoday at 8:30 a.m. Eastern TimeNEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the ...